Free Trial
CVE:SVS

Solarvest BioEnergy (SVS) Stock Price, News & Analysis

Solarvest BioEnergy logo
C$0.02 0.00 (0.00%)
As of 09/5/2023

About Solarvest BioEnergy Stock (CVE:SVS)

Key Stats

Today's Range
C$0.02
C$0.03
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.01
C$0.14
Volume
3,159 shs
Average Volume
77,594 shs
Market Capitalization
C$1.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.

Remove Ads
Receive SVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solarvest BioEnergy and its competitors with MarketBeat's FREE daily newsletter.

SVS Stock News Headlines

Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Solarvest Sells PEI Facility
Solarvest Holdings Bhd Ordinary Shares
See More Headlines

SVS Stock Analysis - Frequently Asked Questions

Solarvest BioEnergy's stock was trading at C$0.03 at the beginning of the year. Since then, SVS shares have increased by 0.0% and is now trading at C$0.03.
View the best growth stocks for 2025 here
.

Shares of SVS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Solarvest BioEnergy investors own include FSD Pharma (HUGE), Nemaska Lithium (NMX), Intercept Pharmaceuticals (ICPT), Sernova (SVA), Routemaster Capital Inc. (RM.V) (RM), IGEN Networks (IGEN) and Clean Energy Pathways (CPWY).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SVS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-2,260,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$740.00
Cash Flow
C$0.00 per share
Price / Cash Flow
55.00
Book Value
C($0.10) per share
Price / Book
-0.25

Miscellaneous

Free Float
N/A
Market Cap
C$1.52 million
Optionable
Not Optionable
Beta
1.50
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (CVE:SVS) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners